Literature DB >> 8101799

Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine.

P H Schaiberger1, T C Kennedy, F C Miller, J Gal, T L Petty.   

Abstract

We present the case of a 33-year-old white male truck driver with a ten-year history of 3.5-g/wk "crank" and "peanut butter methamphetamine" inhalation (methamphetamine and propylhexedrine, respectively). This patient developed marked pulmonary hypertension as a probable consequence of abuse of these drugs. Proposed mechanisms of disease invoke toxic endothelial injury, hypoxic insult, direct spasm, vasculitis, and dysregulation of mediators of vascular tone. The possible role of genetics is discussed in reference to variability of human response to sympathomimetic challenge.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101799     DOI: 10.1378/chest.104.2.614

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  29 in total

Review 1.  Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension.

Authors:  P Egermayer; G I Town; A J Peacock
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

Review 2.  Respiratory toxicities from stimulant use.

Authors:  T E Albertson; W F Walby
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 3.  Drug abuse and HIV-related pulmonary hypertension: double hit injury.

Authors:  Zachery J Harter; Stuti Agarwal; Pranjali Dalvi; Norbert F Voelkel; Navneet K Dhillon
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

4.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

5.  Stimulants and Pulmonary Arterial Hypertension: An Update.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Adv Pulm Hypertens       Date:  2018

6.  Amphetamines promote mitochondrial dysfunction and DNA damage in pulmonary hypertension.

Authors:  Pin-I Chen; Aiqin Cao; Kazuya Miyagawa; Nancy F Tojais; Jan K Hennigs; Caiyun G Li; Nathaly M Sweeney; Audrey S Inglis; Lingli Wang; Dan Li; Matthew Ye; Brian J Feldman; Marlene Rabinovitch
Journal:  JCI Insight       Date:  2017-01-26

Review 7.  Methamphetamine and the risk of pulmonary arterial hypertension.

Authors:  Ramon L Ramirez; Vinicio De Jesus Perez; Roham T Zamanian
Journal:  Curr Opin Pulm Med       Date:  2018-09       Impact factor: 3.155

8.  Drug-Induced Pulmonary Hypertension: The First 50 Years.

Authors:  Vinicio A de Jesus Perez
Journal:  Adv Pulm Hypertens       Date:  2017-01-01

9.  Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology.

Authors:  Jennifer B Treweek; Tobin J Dickerson; Kim D Janda
Journal:  Acc Chem Res       Date:  2009-05-19       Impact factor: 22.384

10.  Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease.

Authors:  Jennifer Treweek; Sunmee Wee; George F Koob; Tobin J Dickerson; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.